Mitsubishi UFJ Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Buy |
|
|||||
|
2025
Q1 | $195K | Buy |
|
|||||
|
2024
Q4 | $215K | Buy |
|
|||||
|
2024
Q3 | $229K | Sell |
|
|||||
|
2024
Q2 | $288K | Buy |
|
|||||
|
2024
Q1 | $227K | Sell |
|
|||||
|
2023
Q4 | $218K | Sell |
|
|||||
|
2023
Q3 | $204K | Buy |
|
|||||
|
2023
Q2 | $247K | Sell |
|
|||||
|
2023
Q1 | $212K | Buy |
|
|||||
|
2022
Q4 | $178K | Sell |
|
|||||
|
2022
Q3 | $292K | Buy |
|
|||||
|
2022
Q2 | $266K | Buy |
|
|||||
|
2022
Q1 | $236K | Buy |
|
|||||
|
2021
Q4 | $275K | Buy |
|
|||||
|
2021
Q3 | $313K | Hold |
|
|||||
|
2021
Q2 | $453K | Sell |
|
|||||
|
2021
Q1 | $401K | Buy |
|
|||||
|
2020
Q4 | $345K | Sell |
|
|||||
|
2020
Q3 | $250K | Sell |
|
|||||
|
2020
Q2 | $220K | Buy |
|
|||||
|
2020
Q1 | $111K | Buy |
|
|||||
|
2019
Q4 | $120K | Sell |
|
|||||
|
2019
Q3 | $150K | Buy |
|
|||||
|
2019
Q2 | $144K | Sell |
|
|||||
|
2019
Q1 | $151K | Buy |
|
|||||
|
2018
Q4 | $112K | Buy |
|
|||||
|
2018
Q3 | $99K | Buy |
|